AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 126.98 billion as of July 2, 2026. Its market cap has decreased by -39.28% in one year.

Market Cap

126.98B

Enterprise Value

122.80B

Revenue

4.27B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,520.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 126.98B, a decrease of -70.00%. That is a compound annual growth rate of -15.67%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2026	126.98B	-49.48%
Dec 30, 2025	251.34B	46.78%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Jun 12, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hana Pharm	156.05B
Hyundai Pharmaceutical	155.00B
Jeil Pharmaceutical Co.,Ltd	148.78B
Daihan Pharmaceutical	147.59B
CMG Pharmaceutical	146.05B
Ilyang Pharmaceutical Co.,Ltd	141.07B
Dongwha Pharm.Co.,Ltd	140.53B
Samil Pharmaceutical Co.,Ltd	140.12B

Market Cap Rankings